|
IN YOUR PRIME
Rx
You’re about to confront some disturbing facts that, perhaps, you didn’t know. If this proves correct,
you’ll be able to tell friends: “I read it first on beoutrageous.com.”
- Did you know between 50,000-100,000 Americans die every year from adverse reactions to pharmaceutical
drugs that have been approved by the Food and Drug Administration? (Admittedly, a portion of blame may lie
with prescribing doctors, hospital nurses, or pharmacists.)
- Mistakes made in “administering drugs, often in hospitals” are the fourth, or sixth, leading cause of death
in the country, report investigators Donald L. Bartlett and James B. Steele, writing in a Time magazine
cover story.
Now, you properly ask: “This being true, why doesn’t the FDA open an inquiry, searching for answers to why
so many needless deaths occur? Or at the very least, conduct a national safety campaign, instructing
seniors on the inherent dangers in drugs—even ones prescribed.”
Instead, the FDA is spending time, and resources, making it difficult (indeed unlawful!) for elderly
citizens to buy American-made drugs in Canada or Mexico? And, purchased at considerable savings to
beleaguered older consumers.
(Note: one-in-four seniors is said to skip doses, or won’t fill a prescription, because the cost is beyond
him or her.)
On average, name brand Rx drugs purchased in Canada cost 40 percent less than in the United States. The
reason is elementary: because health care is the issue, the Canadian government imposes price controls.
Imagine?
Meantime, some 20 other states, from Alabama to Vermont, are considering kinder-gentler drug importation
laws; and, there actually is a National Legislative Assn. on Prescription Drug prices. (Fact: Americans
filled 33 billion prescriptions during 2002; plainly, this controversy is not going away.)
- Consider, the average profit margin of Fortune 500 companies in 2002 was 3.1 percent, while that same
upside margin for the 10 leading drug firms was more than five times greater, at 17 percent.
- And, did you know there are 675 registered Washington lobbyists on drug company payrolls, more than one
for every member of the House of Representatives (435 total), plus the United States Senate (100 total)?
Note: this is in addition to the 81,500 expertly-trained industry sales reps who hit the streets every
workday, handing out free samples and goodies, such as free dinners, cruises and vacation trips to
prescribing doctors and others with influence.
Were you aware the pharmaceutical industry gave nearly $30 million in political contributions last year,
some $21.7 million or 74 percent of the total to the party in power?
- Ready for the drug industry’s sob story? The world’s best pharmaceutical customers (American consumers)
pay the highest prices because manufacturers “need the money for research…” However, with thanks to James
Surowiecki, a writer for The New Yorker, we can report “Big Pharma” is in a big slump:
1) New drug applications to the FDA have fallen 40 percent since 1996, while
2) the FDA approved just 15
drugs during 2002.
Using one manufacturer as an example, Surowiecki reports Merck (“one of history’s most innovative
companies”) has 10,000 people in its R&D (research & development) army and spends $3 billion (yes, billion)
a year in search of new drugs.
“Since 2000,” he writes, “Merck has introduced just three new drugs…(and) eking out less than one product a
year is no way to make a living…(Moreover) a deep sense of anxiety prevails in the industry…most drug
companies have what is known as a pipeline problem.”
Okay, we agree drug development is difficult—and expensive. So, here’s a compromise: in the fallow,
disappointing years of discovery, Big Pharma agrees to drop prices across the board, and in a version of the
“Blue Light Special,” temporarily cuts prices an additional 10 percent for seniors.
|